Group One Trading’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-23,700
Closed -$200K 5419
2015
Q4
$200K Buy
23,700
+23,300
+5,825% +$156K ﹤0.01% 2496
2015
Q3
$2K Sell
400
-1,300
-76% -$5.68K ﹤0.01% 4725
2015
Q2
$9K Buy
+1,700
New +$10.9K ﹤0.01% 4349

Group One Trading's OCAT Position: Q1 2016 in Review

Group One Trading sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 24,639 shares — an estimated $207K sold.

Group One Trading first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $207K in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Group One Trading reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Group One Trading sold 24,639 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $207K.
  • Group One Trading first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Group One Trading's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $207K in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Group One Trading's 13F filing for Q1 2016, filed 12 May 2016.